Genelux (GNLX) Treasury Shares (2022 - 2026)
Genelux's (GNLX) quarterly Treasury Shares came in at $433000.0 in Q1 2026, little changed quarter-over-quarter from $433000.0 in Q4 2025.
Genelux (GNLX) Treasury Shares (2022 - 2026) Analysis & Trends
Genelux's Treasury Shares history runs 5 years deep, the most recent figure standing at $433000.0 for Q1 2026.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $433000.0 in Q1 2026; TTM through Mar 2026 was $433000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $433000.0, changed 0.0% from the prior year.
- Treasury Shares was little changed at $433000.0 in Q1 2026 per GNLX's latest filing, from $433000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q3 2025 and bottomed at -$433333.0 in Q4 2022.
- The 5-year median for Treasury Shares is $0.0 (2022), against an average of $179405.9.
- Biggest YoY gain for Treasury Shares was 0.0% in 2023; the steepest drop was 0.0% in 2023.
- Year by year, Treasury Shares stood at $433000.0 in 2022, then changed by 0.0% to $433000.0 in 2023, then changed by 0.0% to $433000.0 in 2024, then changed by 0.0% to $433000.0 in 2025, then changed by 0.0% to $433000.0 in 2026.
- Per Business Quant, the three latest GNLX Treasury Shares figures stand at $433000.0 (Q1 2026), $433000.0 (Q4 2025), and $433000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 265,401.92 |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 5.14 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433,000.00 |
| Mar 31, 2026 | 1.19 Mn |
| Mar 31, 2026 | 433,000.00 |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Dec 31, 2025 | 433,000.00 |
| Dec 31, 2025 | 433,000.00 |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 433,000.00 |
| Sep 30, 2025 | 1.25 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Sep 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 433,000.00 |
| Jun 30, 2025 | 590,377.00 |
| Jun 30, 2025 | 590,377.00 |
| Mar 31, 2025 | -433,333.00 |
| Mar 31, 2025 | -433,333.00 |
| Dec 31, 2024 | -433,333.00 |
| Dec 31, 2024 | -433,333.00 |